In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity ...
"MetaVia OXM analogue agonist meets endpoints in Phase Ib weight loss trial" was originally created and published by Clinical ...
The Print on MSNOpinion
Does govt spending bring the same economic benefits it once did? Data says no
As the Union Budget 2026 approaches, public capital expenditure is poised to once again take centre stage.
Obexelimab is a monoclonal antibody designed to bind both CD19 and FcγRIIb receptors and inhibit the activity of B-cells linked to autoimmune diseases.
Positive full results from the Phase III TULIP-SC trial showed the subcutaneous administration of Saphnelo demonstrated a statistically ...
Zenas BioPharma shares fell sharply after the company reported favorable Phase 3 study results for obexelimab in immunoglobulin G4-related disease. The stock fell 56% to $15.22. Despite Monday's ...
Food-insecure individuals have fewer total annual visits (in-person and via telehealth) across 4 types of office-based and outpatient visits: general checkup, diagnosis or treatment, psychotherapy or ...
1d
Tenax Therapeutics: How Lower Variance In Phase 3 Has "Loaded The Dice" For An Asymmetric Repricing
The market underappreciates TENX's late-stage pipeline and risk-adjusted asset value; we recommend buying ahead of Phase 3 ...
Obexelimab met the primary endpoint demonstrating a clinically meaningful and highly statistically significant 56% reduction ...
To sum up, GH001 has shown us pretty robust efficacy, a strong safety profile, and durable antidepressant effects. Going into ...
Some scientists are hesitant to submit nonsignificant results to journals, citing reputation as a major factor.
Routine reactor emissions pose no meaningful health risk to the US workers and population, a health physicist and a nuclear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback